and Akkermansia spp., effectively moderating the microbial imbalance and colonic inflammation triggered by experimental colitis, alongside preserving the integrity of the mucus barrier (Ke et al., 2021
Revenue reached approximately $599 million, climbing 49% year over year and exceeding analyst expectations around $579 million to $580 million
The committee plans to further discusses the issue at a meeting in April
The remaining TRIUMPH trials (TRIUMPH-2 in obesity + T2D, TRIUMPH-3 in cardiovascular disease, TRIUMPH-OSA in sleep apnea, TRIUMPH-5 in liver disease, TRIUMPH-6 in chronic low back pain) will expand the label but are not required for the initial obesity approval
(DailyMed) Current tirzepatide safety information
Small amounts of avocado or olive oil are usually well-tolerated, whereas large amounts of fried food often cause issues